State and federal health officials are investigating whether a Massachusetts woman contracted fungal meningitis after receiving steroid shots manufactured by New England Compounding Center, the Framingham specialty pharmacy at the center of a national fungal meningitis outbreak.
Nationwide, 33 people are dead, and more than 475 individuals are infected with fungal meningitis in 19 states.
The Andover woman, 71, received shots for back pain in August, September, and on Oct. 1 at the Merrimack Valley Pain Management Associates in Lawrence, her attorney, Peter G. McGrath told Boston.com.
“Around Oct. 23rd, she became terribly ill, was rushed to the hospital suffering headaches, body aches, fever and all the classic symptoms for meningitis,” McGrath told Boson.com.
The lawyer said the woman's discharge papers Lawrence General Hospital listed her diagnosis as fungal meningitis.
The Food and Drug Administration listing of every medication shipped by New England Compounding since May 21 listed Merrimack Valley Pain Management receiving two shipments of the same kind of steroid in June and July.
NECC originally recalled only 3 lots of the steroids, but later recalled every product it made.
Both Capitol Hill and the Massachusetts Statehouse held hearing on New England Compounding Center this week
The FDA released a list of customers, who received products from NECC in Framingham on or after May 21.